Skip to content

Shear Wave Elastography in Native Kidney Disease

Shear Wave Elastography in Native Kidney Disease: a Pilot Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02830438
Enrollment
8
Registered
2016-07-12
Start date
2016-07-01
Completion date
2018-06-10
Last updated
2020-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Disease, Chronic Kidney Disease

Keywords

kidney disease, fibrosis, ultrasound, elastography

Brief summary

In this proposal, the aim is to examine shear wave elastography (SWE) measurements in diseased native kidneys and correlate them with grades of fibrosis using histological samples. The overall goals of the proposed study are addressed by the following specific aim. Specific aim: To determine whether differences exist in elasticity measurements between native kidneys with and without fibrosis. Hypothesis: Kidneys with higher grades of fibrosis will demonstrate higher measures of tissue elasticity and stiffness compared to kidneys with zero fibrosis.

Detailed description

The proposed project is a prospective cross-sectional study correlating native kidney shear wave elastography (SWE) measurements with histology. Briefly, patients referred for a native kidney biopsy will undergo SWE and the shear wave velocity (SWV) will be correlated with degree of fibrosis determined by a pathologist. A list of patients who recently underwent a native kidney biopsy will be obtained from the pathology department on a weekly basis. Patients will then be contacted about participating in the study and consented during a follow up visit with their nephrologist. After their biopsies, patients will be scheduled to come for a renal ultrasound and SWE. SWE examination will be conducted using an ultrasound machine equipped with a Philips Epiq ARFI Shear wave ElastPQ C1-5 mHz transducer. Shear wave velocity will be obtained and an estimate of tissue elasticity (Young's modulus) will be calculated. All measurements will be performed by one of two qualified radiology physicians who will be blinded to the clinical and pathological data. We will allow a period of 90 days to obtain the images after the biopsy; otherwise the patient is no longer eligible to participate. The primary outcome measure of this study is to determine whether tissue elasticity determined by SWE can assess kidney fibrosis. Linear regression analysis will be performed to describe the relation of the extent of fibrosis and parenchymal stiffness.

Interventions

DEVICEShear wave elastography

Ultrasound technique of the kidneys to assess wave elastography.

Sponsors

Albert Einstein Healthcare Network
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients over 18 years of age who are referred for a native kidney biopsy.

Exclusion criteria

* BMI \> 35 * Patients with polycystic kidney disease, renal cell carcinoma, hydronephrosis or renal stones. * Patients who develop severe post biopsy complications (infection, significant bleeding requiring transfusion or intervention) * Pregnant patients.

Design outcomes

Primary

MeasureTime frameDescription
Shear Wave Velocity of Kidney Parenchyma6 monthsThe shear wave velocity of the kidneys will be determined using the elastography ultrasound machine. This will enable us to calculate the tissue elasticity using a standard formula. Shear wave velocity is measured in meters per second, at a range of 0-5 m/s with the highest number reporting hard consistency (fibrosis - worse outcome).

Countries

United States

Participant flow

Recruitment details

Outpatient

Participants by arm

ArmCount
Shear Wave Elastography Group
Patients referred for kidney biopsy will then undergo shear wave elastography measurements. Shear wave elastography: Ultrasound technique of the kidneys to assess wave elastography.
8
Total8

Baseline characteristics

CharacteristicShear Wave Elastography Group
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
3 Participants
Age, Categorical
Between 18 and 65 years
5 Participants
Age, Continuous52.1 years
Race/Ethnicity, Customized
African American
3 Participants
Race/Ethnicity, Customized
Caucasian
2 Participants
Race/Ethnicity, Customized
Hispanic/Latino
3 Participants
Region of Enrollment
United States
8 Participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 8
other
Total, other adverse events
0 / 8
serious
Total, serious adverse events
0 / 8

Outcome results

Primary

Shear Wave Velocity of Kidney Parenchyma

The shear wave velocity of the kidneys will be determined using the elastography ultrasound machine. This will enable us to calculate the tissue elasticity using a standard formula. Shear wave velocity is measured in meters per second, at a range of 0-5 m/s with the highest number reporting hard consistency (fibrosis - worse outcome).

Time frame: 6 months

ArmMeasureValue (MEDIAN)Dispersion
Shear Wave Elastography GroupShear Wave Velocity of Kidney Parenchyma0.21 meters per secondStandard Deviation 0.71

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026